The cost of major comorbidity in people with diabetes mellitus
Related Experiment Videos
Scot H Simpson1, Paula Corabian, Philip Jacobs
1Institute of Health Economics, Edmonton, Alta.
Insights
Diabetes complications significantly increase healthcare costs in Canada. Managing comorbidities like cardiovascular, renal, and ophthalmic issues is crucial for reducing the economic burden of diabetes mellitus.
Area of Science:
- Health Economics
- Public Health
- Diabetes Management
Background:
- Diabetes mellitus is associated with higher rates of cardiovascular, renal, and ophthalmic comorbidities.
- Limited data exists on the economic impact of diabetes and its complications within the Canadian healthcare system.
Purpose of the Study:
- To estimate healthcare expenditures for diabetes and its major complications in Saskatchewan.
- To analyze the cost distribution across cardiovascular, renal, and ophthalmic services.
Main Methods:
- Utilized Saskatchewan Health administrative databases from 1996 to identify individuals with diabetes.
- Categorized healthcare utilization and expenditures (prescription drugs, physician services, hospitalizations, dialysis) by comorbidity type.
Main Results:
- In 1996, an estimated $134.3 million was spent on diabetes-related care and complications in Saskatchewan.
- Cardiovascular services accounted for the largest portion ($35.5 million), followed by renal ($10 million) and ophthalmic ($3.3 million) services.
- Registered Indigenous individuals showed different comorbidity patterns, with fewer cardiovascular and more renal-related records.
Conclusions:
- Approximately 36.4% of diabetes-related healthcare expenditures were attributed to major comorbidities in 1996.
- Implementing strategies to prevent or manage these comorbidities can lead to substantial cost savings for the healthcare system.
Background:
People with diabetes mellitus are more likely to have cardiovascular, renal and ophthalmic comorbidity than those without diabetes. Information on the economic impact of diabetes and its complications on the Canadian health care system is limited.
Methods:
To estimate health care expenditures for diabetes and its major complications, we identified people with diabetes in 1996 in Saskatchewan, using the administrative databases of Saskatchewan Health. We grouped utilization and expenditure data for prescription drugs, physician services, hospitalizations, day surgery procedures and dialysis services according to cardiovascular, renal and ophthalmic services, according to billing codes and the American Hospital Formulary Services classification for prescription drugs.
Results:
Of the 38 124 people identified (48.5% female and 9.7% registered Indians), 46.6% had cardiovascular-related records, 19.8% ophthalmic-related records and 6.6% renal-related records. Registered Indians had significantly fewer (p < 0.001) cardiovascular-related records than the rest of the diabetic population (35.1% v. 47.9%, respectively) but more renal- related records (11.7% v. 6.0%, respectively). The total 1996 Saskatchewan Health expenditure for the study group, within the observed categories, was estimated to be $134.3 million, of which $35.5 million (26.4%) was for cardiovascular-related services, $10 million (7.5%) for renal-related services and $3.3 million (2.5%) for ophthalmic-related services.
Interpretation:
In 1996, 36.4% of health care expenditures for people with diabetes was attributable to major comorbidity. Actions to prevent or control such comorbidity will yield significant cost savings.
Related Concept Videos
Complications of Diabetes Mellitus
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Introduction
Type I Diabetes III: Clinical Manifestations